Abstract:OBJECTIVES: Split dose of 4 l polyethylene glycol (PEG) is currently the standard regimen for bowel preparation (BP). However, it may be unnecessary for patients without high risks (e.g., old age, constipation, and diabetes, and so on) for inadequate BP. The study aimed to compare the efficacy of bowel cleansing between low-risk patients receiving same-day, single dose of low-volume (SSL) PEG vs. standard regimen. METHODS: This prospective, randomized, observer-blinded, non-inferiority study enrolled low-risk patients in three centers. Patients undergoing colonoscopy were randomized (1:1) to the SSL or standard group. The primary outcome was adequate BP, defined by Boston Bowel Preparation Score (BBPS) >= 6 and each segmental score >= 2. Secondary outcomes included adverse events, cecal intubation rate, and patient willingness to repeat BP, and so on. RESULTS: Among 2,532 patients eligible for the study, 940 (37.1%) were at low risk and 792 (31.3%) at high risk for inadequate BP. The low-risk patients were randomly allocated to the SSL (n=470) or standard group (n=470). The baseline characteristics of the two groups were similar. Intention-to-treat analysis showed that adequate BP was achieved in 88.1% in the SSL group and 87.0% in the standard group (relative risk (RR) 1.10, 95% confi dence interval (CI): 0.75-1.63, P=0.621). The overall BBPS was 7.3 +/- 1.2 and 7.3 +/- 1.3, respectively (P=0.948). No significant differences were found between the two groups with regards to the right, transverse, and left-segmental colon BBPS (all P>0.05). However, in terms of adverse events, patients in the SSL group reported less nausea (19.6% vs. 29.9%), vomiting (5.3% vs. 11.4%), and abdominal discomfort (2.2% vs. 6.0%) compared with those in the standard group. More patients in the SSL group were willing to repeat BP (94.0% vs. 89.5%, P=0.015). CONCLUSIONS: For low-risk patients, the SSL regimen was not inferior to the split dose of 4 l PEG for adequacy of BP. Single dose of low-volume regimen had significantly fewer adverse events. This simplified regimen may be preferable in the "easy-to prepare" population. SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/ajg

Superior bowel preparation quality for colonoscopy with 1L-PEG compared to 2L-PEG and picosulphate: Data from a large real-world retrospective outpatient cohort

Oral sulfate solution versus polyethylene glycol for colonoscopy bowel preparation: a randomized controlled study in phase Ⅲ

Comparison of Two Litre Polyethylene Glycol Plus Bisacodyl Versus Four Litre Polyethylene Glycol As Preparation for Colonoscopy in Colon Disease: a Systemic Review and Meta-Analysis

Effectiveness of 4 L, 2 L, and 1 L PEG Bowel Preparation for Colonoscopy in Patients with Ulcerative Colitis: A Retrospective Study

Real-word Evaluation of Differences in Bowel Preparation for Colonoscopy Between the Digestive and the Non-Digestive Physicians: A Retrospective Study

Efficacy and tolerability of 1 L polyethylene glycol plus ascorbic acid with senna versus 2 L polyethylene glycol plus ascorbic acid for colonoscopic bowel preparation: Prospective, randomized, investigator-blinded trial

Same-Day Single Dose of 2 Liter Polyethylene Glycol is Not Inferior to The Standard Bowel Preparation Regimen in Low-Risk Patients: A Randomized, Controlled Trial.

Individualized intervention based on a preparation-related prediction model improves adequacy of bowel preparation: A prospective, multi-center, randomized, controlled study

Effectiveness and safety of a 1-L polyethylene glycol and ascorbic acid preparation for colonoscopy in routine clinical practice in Spain

Cleaning effect and tolerance of 16 bowel preparation regimens on adult patients before colonoscopy: a network meta-analysis

Comparison of the efficacy and safety of an oral sulfate solution and 3-liter polyethylene glycol on bowel preparation before colonoscopy: a phase III multicenter randomized controlled trial

Randomized clinical trial of a split-dose bowel preparation with 2L polyethylene glycol plus castor oil versus 1L polyethylene glycol plus castor oil and ascorbic acid before colonoscopy

Patient-directed vs. fixed-volume PEG for colonoscopy preparation: a randomized controlled trial

3 L split-dose polyethylene glycol is superior to 2 L polyethylene glycol in colonoscopic bowel preparation in relatively high-BMI (≥ 24 kg/m2) individuals: a multicenter randomized controlled trial

Comparison of the Efficacy and Safety of an Oral Sulfate Solution and 3-L Polyethylene Glycol on Bowel Preparation Before Colonoscopy: a Phase III Multicenter Randomized Controlled Trial.

Probiotics for managing patients after bowel preparation for colonoscopy: an interventional, double-arm, open, randomized, multi-center, and national study (COLONSTUDY)

Randomized Controlled Trial: Standard Versus Supplemental Bowel Preparation In Patients With Bristol Stool Form 1 And 2

Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases

Split doses versus whole dose bowel preparation using polyethylene glycol for colonoscopy: A multicentric prospective Lebanese randomized trial between 2021 and 2023

Effectiveness and safety of polyethylene‐glycol‐4000 versus sodium picosulphate plus magnesium oxide and citric acid for bowel cleansing before colonoscopy in children: A systematic review with meta‐analysis

Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol + ascorbate or oral sulfate solution